Cilastatin Sodium

西司他丁钠

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameCilastatin Sodium
Drug Alias NameCilastatinoMK-791L-642957
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEnzymes inhibitors
TargetsEnzymes
Therapy Area/IndicationsCommunicable Diseases
Global Approved IndicationsCommunicable Diseases
Approved Indications in ChinaCommunicable Diseases
Original Approved Country/TerritoryMainland China
Original Approved Date2000/05/27
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesMerck & Co Inc
Inactive CompaniesN/A
Active IndicationsCommunicable Diseases
Inactive IndicationsN/A

Other Information

ATC CodeV07AY